Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1

Alcohol

Volumn 44, Issue 6, 2010, Pages 495-506

  Menk, Mario ^a   von Haefen, Clarissa ^a   Funke Kaiser, Heiko ^a   Sifringer, Marco ^a   Schefe, Jan H ^a   Kirsch, Sebastian ^a   Seidel, Kerstin ^a   Reinemund, Jana ^a   Steckelings, Ulrike M ^a   Unger, Thomas ^a   Spies, Claudia D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcohol; Angiotensin II AT2 receptor; Ethanol; Gene regulation; PARP 1; Renin angiotensin system

Indexed keywords

ALCOHOL; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; HEAT SHOCK PROTEIN 32; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOWN REGULATION; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC VARIABILITY; IN VITRO STUDY; KNOCKOUT GENE; MOUSE; NONHUMAN; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; DOWN-REGULATION; ETHANOL; FIBROBLASTS; HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; NEUROBLASTOMA; PC12 CELLS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS, GENETIC; RATS; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER;

MURINAE;

EID: 77956648729     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2010.05.005     Document Type: Article

References (48)

1. Anderson M.G., Scoggin K.E., Simbulan-Rosenthal C.M., Steadman J.A. Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J. Virol. 2000, 74:2169-2177.
2. Ballardini G., Fallani M., Biagini G., Bianchi F.B., Pisi E. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1988, 56:45-49.
3. Baker R.C., Kramer R.E. Cytotoxicity of short-chain alcohols. Annu. Rev. Pharmacol. Toxicol. 1999, 39:127-150.
4. Bauer M., Bauer I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid. Redox. Signal. 2002, 4:749-758.
5. Bechara R.I., Brown L.A., Eaton D.C., Roman J., Guidot D.M. Chronic ethanol ingestion increases expression of the angiotensin II type 2 (AT2) receptor and enhances tumor necrosis factor-alpha- and angiotensin II-induced cytotoxicity via AT2 signaling in rat alveolar epithelial cells. Alcohol. Clin. Exp. Res. 2003, 27:1006-1014.
6. Bove C.M., Gilson W.D., Scott C.D., Epstein F.H., Yang Z., Dimaria J.M., et al. The angiotensin II type 2 receptor and improved adjacent region function post-MI. J. Cardiovasc. Magn. Reson. 2005, 7:459-464.
7. Butler A.J., Ordahl C.P. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol. Cell Biol. 1999, 19:296-306.
8. Cervellera M.N., Sala A. Poly(ADP-ribose) polymerase is a B-MYB coactivator. J. Biol. Chem. 2000, 275:10692-10696.
9. Cherian P.P., Schenker S., Henderson G.I. Ethanol-mediated DNA damage and PARP-1 apoptotic responses in cultured fetal cortical neurons. Alcohol. Clin. Exp. Res. 2008, 32:1884-1892.
10. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342:249-268.
11. Foo R.S., Siow R.C., Brown M.J., Bennett M.R. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy. J. Cell. Physiol. 2006, 209:1-7.
12. Funke-Kaiser H., Lemmer J., Langsdorff C.V., Thomas A., Kovacevic S.D., Strasdat M., et al. Endothelin-converting enzyme-1 (ECE-1) is a downstream target of the homeobox transcription factor Nk×2-5. FASEB J. 2003, 17:1487-1489.
13. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 2002, 52:415-472.
14. Gressner A.M., Schuppan D. Cellular and molecular pathobiology, pharmacological intervention, and biochemical assessment of liver fibrosis. Oxford Textbook of Clinical Hepatology 1999, Vol. 2:607-627. Oxford University Press, Oxford. 2nd ed. J. Bircher, J.-P. Benhamou, N. McIntyre, M. Rizzetto, J. Rodes (Eds.).
15. Guo L., Yang J.Y., Wu C.F. Oxidative DNA damage induced by ethanol in mouse peripheral leucocytes. Basic. Clin. Pharmacol. Toxicol. 2008, 103:222-227.
16. Guyot R., Lepreux S., Combe C., Doudnikoff E., Bioulac-Sage P., Balabaud C., et al. Hepatic fibrosis and cirrhosis: the (myo-) fibroblastic cell subpopulations involved. Int. J. Biochem. Cell Biol. 2006, 38:135-145.
17. Hassa P.O., Hottiger M.O. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol. Life Sci. 2002, 59:1534-1553.
18. Helmy A., Jalan R., Newby D.E., Hayes P.C., Webb D.J. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology 2000, 118:565-572.
19. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436:112-116.
20. Iwai M., Chen R., Li Z., Shiuchi T., Suzuki J., Ide A., et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005, 112:1636-1643.
21. Iwai M., Liu H.W., Chen R., Ide A., Okamoto S., Hata R., et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004, 110:843-848.
22. Jagtap P., Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 2005, 4:421-440.
23. Johnsson J.R., Cloustin A.D., Ando Y., Kelemen L.I., Horn M.J., Adamson M.D., et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001, 121:148-155.
24. Kim Y.D., Eom S.Y., Ogawa M., Oyama T., Isse T., Kang J.W., et al. Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice. J. Occup. Health 2007, 49:363-369.
25. Kraus W.L., Lis J.T. PARP goes transcription. Cell 2003, 113:677-683.
26. Ku B.M., Joo Y., Mun J., Roh G.S., Kang S.S., Cho G.J., et al. Heme oxygenase protects neurons from ethanol-induced neurotoxicity. Neurosci. Lett. 2006, 405:168-171.
27. Li J., Culman J., Hörtnagl H., Zhao Y., Gerova N., Timm M., et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005, 19:617-619.
28. Liu Z.M., Chen G.G., Ng E.K., Leung W.K., Sung J.J., Chung S.C. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 2004, 23:503-513.
29. Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J., Unger T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 1998, 188:661-670.
30. Meyer C., Meindl-Beinker N.M., Dooley S. TGF-beta signaling in alcohol induced hepatic injury. Front. Biosci. 2010, 15:740-749.
31. Miyamoto T., Kakizawa T., Hashizume K. Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase. Mol. Cell. Biol. 1999, 19:2644-2649.
32. de Murcia G., Ménissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci. 1994, 19:172-176. Review. Erratum in: Trends Biochem. Sci. 19, 250.
33. Paizis G., Cooper M.E., Schembri J.E., Tikellis C., Burrell L.E., Angus P.W. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002, 213:1667-1676.
34. Patriarca S., Furfaro A.L., Cosso L., Pesce Maineri E., Balbis E., Domenicotti C., et al. Heme oxygenase 1 expression in rat liver during ageing and ethanol intoxication. Biogerontology 2007, 8:365-372.
35. Reinecke K., Lucius R., Reinecke A., Rickert U., Herdegen T., Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. 2003, 17:2094-2096.
36. Reinemund J., Seidel K., Steckelings U.M., Zaade D., Klare S., Rompe F., et al. Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem. Pharmacol. 2009, 77:1795-1805.
37. Salaspuro M. Epidemiological aspects of alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury. Oxford Textbook of Clinical Hepatology 1999, Vol. 2:1157-1178. Oxford University Press, Oxford. 2nd ed. J. Bircher, J.-P. Benhamou, N. McIntyre, M. Rizzetto, J. Rodes (Eds.).
38. Shen L., Mo H., Cai L., Kong T., Zheng W., Ye J., et al. Sartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock 2009, 31:500-506.
39. Soldatenkov V.A., Chasovskikh S., Potaman V.N., Trofimova I., Smulson M.E., Dritschilo A. Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J. Biol. Chem. 2002, 277:665-670.
40. Steckelings U.M., Kaschina E., Unger T. The AT2 receptor: a matter of love and hate. Peptides 2005, 26:1401-1409.
41. Stoll M., Steckelings U.M., Paul M., Bottari S.P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 1995, 95:651-657.
42. Szabó S.C., Dawson V. Role of poly(ADP-ribose) synthetase in inflammation and ischemia-reperfusion. Trends Pharmacol. Sci. 1998, 19:287-298.
43. Tulin A., Spradling A. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 2003, 29:560-562.
44. Ulmasov B., Xu Z., Tetri L.H., Inagami T., Neuschwander-Tetri B.A. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G284-G294.
45. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am. J. Cardiol. 2002, 89(2A):3A-9A. discussion 10A.
46. Virág L., Szabó C. The potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 2002, 54:375-429.
47. Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?. J. Hypertens. 2003, 21:1429-1443.
48. Yao P., Hao L., Nussler N., Lehmann A., Song F., Zhao J., et al. The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1318-G1323.